Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Laser eye surgery showdown: which technique gives the best vision?

NCT ID NCT07201298

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares a new type of LASIK (Ray-Tracing Guided) with three other common laser eye surgeries (SMILE, Wavefront Optimized LASIK, and Topography Guided LASIK) to see which one provides the best vision after surgery. Researchers will enroll 120 people with nearsightedness (with or without astigmatism) and follow them for 12 months. The goal is to measure how many people achieve 20/20 vision or better without glasses.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Laser eye surgery (LASIK and SMILE)
What this could lead to
If successful, this could show which laser eye surgery technique gives the sharpest vision with the fewest side effects for nearsighted people.
What could go wrong
This is a small, early-phase study (120 people) comparing existing techniques, not testing a new cure. Results may not apply to everyone, and all laser surgeries carry risks like dry eyes or glare.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2025

An estimate. Start dates often move.

Expected to finish

Sep 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

22 to 50 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age 22-50 at the time of consent 2. Diagnosis of myopia or myopia with astigmatism with Preoperative manifest spherical equivalent refraction of ≥ -2.00 and ≤ -9.00 D (-2.00 D through -9.00 D) 3. Preop Spherical component of ≥ -2.00 and ≤ -8.00 D (-2.00 D through -8.00 D) 4. Refractive Cylinder of ≤ -3.00 D (0.00 through -3.00 D) 5. BCVA of 20/20 or better in each eye (83 or more letters on the ETDRS Chart) 6. Subjects must have a stable refraction which is defined as a change in spherical equivalent no greater than 0.50 D comparing the screening visit manifest refraction to a previous refraction, spectacle Rx, or contact lens Rx, 12 months or older. 7. Subjects who are contact lens wearers must discontinue the use of soft lenses (spherical or toric) for at least 5 days and hard or gas-permeable lenses for at least 4 weeks prior to the preoperative screening evaluation. Hard or gas-permeable lens wearers must not return to contact lens use before surgery. Soft lens wearers may resume contact lens wear after all preoperative testing is completed, but must discontinue lens use at least 5 days before surgery. 8. Acceptable preoperative tomography and examination results for refractive procedures as determined by the Principal Investigator. 9. Surgical plan includes treatment target for emmetropia in both eyes, and no monovision. 10. Subject is capable and willing to use postoperative medications as prescribed. 11. Subject has ability to successfully complete all preoperative and postoperative questionnaires, testing, and exam visits. 12. Subject is willing and able to return for all postoperative examinations. Exclusion Criteria: 1. Clinically significant dry eye on clinical examination, as determined by the investigator 2. Irregular astigmatism, keratoconus, keratoconus suspect, or abnormal corneal tomography 3. History of corneal dystrophies or guttata 4. History of herpetic keratitis or active disease 5. History of prior refractive surgery 6. History of glaucoma or glaucoma suspect 7. History of uncontrolled diabetes, unstable hypertension, or unstable autoimmune disease. 8. Females who are pregnant, breastfeeding, or intend to become pregnant any time during the study as determined by verbal inquiry. 9. The Principal Investigator has determined the subject not to be a good candidate for the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Astigmatism are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hoopes Moshirfar Research Center

    RECRUITING

    Draper, Utah, 84020, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.